{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:44:49Z","timestamp":1788684289982,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.sult.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:59:50Z","timestamp":1780963190000},"page":"149-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic Neuroendocrine Neoplasms"],"prefix":"10.1053","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0862-0741","authenticated-orcid":false,"given":"Ananya","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Mhlanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofrio Antonio","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Lall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Arif-Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.sult.2026.06.001_bib1","unstructured":"National Comprehensive Cancer Network. Neuroendocrine and Adrenal Tumors (Version 3.2025). Accessed December 2025. \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf\u3009."},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.15798","article-title":"Epidemiology of Neuroendocrine Neoplasms in the US","volume":"8","author":"Dasari","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","article-title":"Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER database analysis","volume":"27","author":"Sonbol","year":"2022","journal-title":"Oncologist"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81518-4","article-title":"Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Uhlig","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1053\/j.sult.2026.06.001_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.suc.2019.04.014","article-title":"Evaluation and management of neuroendocrine tumors of the pancreas","volume":"99","author":"Scott","year":"2019","journal-title":"Surg Clin North Am"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society Consensus Paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2967\/jnumed.118.230607","article-title":"NANETS\/SNMMI procedure standard for somatostatin receptor-based peptide receptor radionuclide therapy with (177)Lu-DOTATATE","volume":"60","author":"Hope","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.sult.2026.06.001_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcancer.2025.03.005","article-title":"Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis","volume":"112","author":"Tacelli","year":"2025","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5662\/wjm.v7.i1.9","article-title":"Chromogranin A as a valid marker in oncology: clinical application or false hopes?","volume":"7","author":"Gkolfinopoulos","year":"2017","journal-title":"World J Methodol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bpg.2012.12.006","article-title":"Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)","volume":"26","author":"Kanakis","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors","volume":"49","author":"Halfdanarson","year":"2020","journal-title":"Pancreas"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/endocrines6030038","article-title":"Functional pancreatic neuroendocrine neoplasms: an overview","volume":"6","author":"Mills","year":"2025","journal-title":"Endocrines"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/jcm9051363","article-title":"Serotonin-secreting neuroendocrine tumours of the pancreas","volume":"9","author":"Milanetto","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1053\/j.sult.2026.06.001_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.soc.2015.12.003","article-title":"Clinical presentation and diagnosis of pancreatic neuroendocrine tumors","volume":"25","author":"Anderson","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib16","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1007\/s00261-022-03466-9","article-title":"Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists","volume":"47","author":"Galgano","year":"2022","journal-title":"Abdom Radiol"},{"issue":"4","key":"10.1053\/j.sult.2026.06.001_bib17","first-page":"359","article-title":"Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors","volume":"74","author":"Chauhan","year":"2024","journal-title":"CA A Cancer J Clin"},{"issue":"8","key":"10.1053\/j.sult.2026.06.001_bib18","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1245\/s10434-024-15597-y","article-title":"AJCC Cancer Staging System Version 9: practice-informing updates for gastroenteropancreatic neuroendocrine tumors","volume":"31","author":"Chan","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.sult.2026.06.001_bib19","unstructured":"James D. Brierley M.G., Brian O.'Sullivan, Brian Rous, Elizabeth Van Eycken. TNM Classification of Malignant Tumours, 9th Edition. 9 ed. 2025."},{"issue":"4","key":"10.1053\/j.sult.2026.06.001_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","article-title":"Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases","volume":"38","author":"Basturk","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061437","article-title":"Poorly differentiated neuroendocrine tumors of the pancreas: a comparative analysis of primary versus secondary tumors-a literature review","volume":"13","author":"Markov","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1053\/j.sult.2026.06.001_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000354754","article-title":"Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma","volume":"6","author":"Fonseca","year":"2013","journal-title":"Case Rep Oncol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib24","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.3390\/curroncol28060388","article-title":"Complete and durable response to nivolumab in recurrent poorly differentiated pancreatic neuroendocrine carcinoma with high tumor mutational burden","volume":"28","author":"Kang","year":"2021","journal-title":"Curr Oncol"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib25","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00261-022-03737-5","article-title":"Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios","volume":"48","author":"Konstantinoff","year":"2023","journal-title":"Abdom Radiol"},{"issue":"1080","key":"10.1053\/j.sult.2026.06.001_bib26","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170411","article-title":"Dual energy CT applications in pancreatic pathologies","volume":"90","author":"George","year":"2017","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11547-023-01733-3","article-title":"Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas","volume":"129","author":"Hu","year":"2024","journal-title":"La Radiol Med"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pan.2020.10.046","article-title":"Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors","volume":"21","author":"Wan","year":"2021","journal-title":"Pancreatology"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12880-024-01511-1","article-title":"Quantitative evaluation of pancreatic neuroendocrine tumors utilizing dual-source CT perfusion imaging","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Med Imaging"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib30","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00330-015-3941-7","article-title":"Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma","volume":"26","author":"Kim","year":"2016","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1053\/j.sult.2026.06.001_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2214\/AJR.17.18417","article-title":"Prediction of pancreatic neuroendocrine tumor grade based on CT features and texture analysis","volume":"210","author":"Canellas","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib32","doi-asserted-by":"crossref","DOI":"10.2484\/rcr.v3i3.162","article-title":"Pancreatic neuroendocrine tumor with atypical radiologic presentation","volume":"3","author":"Singh","year":"2008","journal-title":"Radiol Case Rep"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib33","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1007\/s00261-019-01994-5","article-title":"The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI","volume":"44","author":"Rozenblum","year":"2019","journal-title":"Abdom Radiol"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib34","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s00261-022-03430-7","article-title":"Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome","volume":"47","author":"Yano","year":"2022","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.surg.2014.03.026","article-title":"A systematic review and meta-analysis of the clinicopathologic characteristics of cystic versus solid pancreatic neuroendocrine neoplasms","volume":"156","author":"Koh","year":"2014","journal-title":"Surgery"},{"issue":"9","key":"10.1053\/j.sult.2026.06.001_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/14737140.2018.1496822","article-title":"Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies","volume":"18","author":"Lee","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib37","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1007\/s00261-022-03713-z","article-title":"Neuroendocrine neoplasm imaging: protocols by site of origin","volume":"47","author":"Martin","year":"2022","journal-title":"Abdom Radiol"},{"issue":"10","key":"10.1053\/j.sult.2026.06.001_bib38","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1007\/s00261-021-03129-1","article-title":"Dual contrast liver MRI: a pictorial illustration","volume":"46","author":"Welle","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ro.2024.12.001","article-title":"Imaging update of pancreatic neuroendocrine neoplasms","volume":"60","author":"Rupe","year":"2025","journal-title":"Semin Roentgenol"},{"issue":"2","key":"10.1053\/j.sult.2026.06.001_bib40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1148\/radiol.13121628","article-title":"High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging","volume":"268","author":"d\u2019Assignies","year":"2013","journal-title":"Radiology"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000446369","article-title":"Impact of liver and whole-body diffusion-weighted MRI for neuroendocrine tumors on patient management: a pilot study","volume":"104","author":"Moryoussef","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mric.2018.03.010","article-title":"MR imaging of pancreatic neuroendocrine tumors","volume":"26","author":"Lo","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"4","key":"10.1053\/j.sult.2026.06.001_bib43","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s00330-016-4539-4","article-title":"Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging","volume":"27","author":"Lotfalizadeh","year":"2017","journal-title":"Eur Radiol"},{"issue":"43","key":"10.1053\/j.sult.2026.06.001_bib44","doi-asserted-by":"crossref","first-page":"75434","DOI":"10.18632\/oncotarget.20406","article-title":"Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADC(mean)","volume":"8","author":"Surov","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1053\/j.sult.2026.06.001_bib45","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s11547-025-02080-1","article-title":"68)Ga-DOTATATE PET\/CT versus MRI in neuroendocrine liver metastases: a comprehensive per-lesion analysis","volume":"130","author":"Herold","year":"2025","journal-title":"Radiol Med"},{"key":"10.1053\/j.sult.2026.06.001_bib46","article-title":"Per-lesion assessment of individual MRI sequences and 68Ga-DOTATATE PET in neuroendocrine liver metastases","author":"Herold","year":"2025","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/onco5030036","article-title":"Imaging of liver metastases from GEP-NETs: a narrative review","volume":"5","author":"Posa","year":"2025","journal-title":"Onco"},{"issue":"23","key":"10.1053\/j.sult.2026.06.001_bib48","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.3748\/wjg.v19.i23.3678","article-title":"Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: a systematic review and meta analysis","volume":"19","author":"Puli","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1053\/j.sult.2026.06.001_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jviscsurg.2017.12.008","article-title":"Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors","volume":"155","author":"Deguelte","year":"2018","journal-title":"J Visc Surg"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S2468-1253(19)30081-0","article-title":"Molecular radionuclide imaging of pancreatic neoplasms","volume":"4","author":"Panda","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1053\/j.sult.2026.06.001_bib52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/apm.13297","article-title":"Immunohistochemical somatostatin receptor expression in insulinomas","volume":"131","author":"Peltola","year":"2023","journal-title":"APMIS"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib53","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2967\/jnumed.116.179234","article-title":"Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions","volume":"57","author":"Deroose","year":"2016","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.116.180430","article-title":"Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors","volume":"58","author":"Johnbeck","year":"2017","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2967\/jnumed.120.244509","article-title":"64)Cu-DOTATATE PET in patients with neuroendocrine neoplasms: prospective, head-to-head comparison of imaging at 1 Hour and 3\u2009h After Injection","volume":"62","author":"Loft","year":"2021","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2967\/jnumed.116.185587","article-title":"The impact of somatostatin receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis","volume":"58","author":"Barrio","year":"2017","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib57","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1007\/s00261-022-03713-z","article-title":"Neuroendocrine neoplasm imaging: protocols by site of origin","volume":"47","author":"Martin","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"10","key":"10.1053\/j.sult.2026.06.001_bib58","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2967\/jnumed.120.251512","article-title":"Somatostatin receptor imaging and theranostics: current practice and future prospects","volume":"62","author":"Park","year":"2021","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.sult.2026.06.001_bib59","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00259-019-04455-9","article-title":"Prognostic value of somatostatin receptor expressing tumor volume calculated from (68)Ga-DOTATATE PET\/CT in patients with well-differentiated neuroendocrine tumors","volume":"46","author":"Toriihara","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib60","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2967\/jnumed.121.262652","article-title":"Prognostic value of whole-body PET volumetric parameters extracted from 68Ga-DOTATOC PET\/CT in well-differentiated neuroendocrine tumors","volume":"63","author":"Thuillier","year":"2022","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00259-019-04452-y","article-title":"PET\/MRI versus PET\/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations","volume":"47","author":"Mayerhoefer","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mric.2020.03.010","article-title":"PET\/magnetic resonance imaging applications in abdomen and pelvis","volume":"28","author":"Panda","year":"2020","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"9","key":"10.1053\/j.sult.2026.06.001_bib63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/RLU.0000000000001753","article-title":"Whole-body 68Ga-DOTANOC PET\/MRI versus 68Ga-DOTANOC PET\/CT in patients with neuroendocrine tumors: a prospective study in 28 patients","volume":"42","author":"Berzaczy","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib64","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00261-015-0409-9","article-title":"Simultaneous 68Ga-DOTA-TOC PET\/MRI with gadoxetate disodium in patients with neuroendocrine tumor","volume":"40","author":"Hope","year":"2015","journal-title":"Abdom Imaging"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib65","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00259-023-06406-x","article-title":"International EANM-SNMMI-ISMRM consensus recommendation for PET\/MRI in oncology","volume":"50","author":"Veit-Haibach","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1053\/j.sult.2026.06.001_bib66","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11547-018-0917-0","article-title":"Fast non-enhanced abdominal examination protocols in PET\/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET\/CT","volume":"123","author":"Seith","year":"2018","journal-title":"Radiol Med"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib67","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.119.234062","article-title":"Quantitative 3D assessment of 68Ga-DOTATOC PET\/MRI with diffusion-weighted imaging to assess imaging markers for gastroenteropancreatic neuroendocrine tumors: preliminary results","volume":"61","author":"Adams","year":"2020","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib68","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1007\/s00261-022-03516-2","article-title":"PET\/CT and PET\/MRI in neuroendocrine neoplasms","volume":"47","author":"Rajamohan","year":"2022","journal-title":"Abdom Radiol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40336-019-00344-1","article-title":"PET\/MRI for neuroendocrine tumors: a match made in heaven or just another hype?","volume":"7","author":"Pirasteh","year":"2019","journal-title":"Clin Transl Imaging"},{"issue":"3","key":"10.1053\/j.sult.2026.06.001_bib70","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/jc.2010-2022","article-title":"Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (\u226510%) well-differentiated endocrine carcinoma staging","volume":"96","author":"Abgral","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib71","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"issue":"6","key":"10.1053\/j.sult.2026.06.001_bib72","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2967\/jnumed.108.057505","article-title":"Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors","volume":"50","author":"Garin","year":"2009","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib73","first-page":"58","article-title":"Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]\/[18F]-HTP)","volume":"59","author":"Ambrosini","year":"2015","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.sult.2026.06.001_bib74","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2967\/jnumed.115.157446","article-title":"90Y Hepatic radioembolization: an update on current practice and recent developments","volume":"56","author":"Braat","year":"2015","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1053\/j.sult.2026.06.001_bib75","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2967\/jnumed.125.270979","article-title":"Summary: SNMMI\/ACNM procedure standard for posttreatment imaging of (177)Lu-based radiopharmaceuticals","volume":"66","author":"Uribe","year":"2025","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.sult.2026.06.001_bib76","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.120.257808","article-title":"Updates to the appropriate-use criteria for somatostatin receptor PET","volume":"61","author":"Hope","year":"2020","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib77","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1530\/EC-16-0043","article-title":"A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management","volume":"5","author":"Oberg","year":"2016","journal-title":"Endocr Connect"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib78","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2214\/AJR.21.27159","article-title":"Imaging of neuroendocrine neoplasms: monitoring treatment response\u2014AJR expert panel narrative review","volume":"218","author":"Galgano","year":"2022","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1053\/j.sult.2026.06.001_bib79","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2967\/jnumed.124.268621","article-title":"PET- and CT-based imaging criteria for response assessment of gastroenteropancreatic neuroendocrine tumors under radiopharmaceutical therapy","volume":"66","author":"Herr","year":"2025","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.sult.2026.06.001_bib80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1067\/j.cpradiol.2024.10.003","article-title":"Comparison of RECIST 1.1, mRECIST and PERCIST for assessment of peptide receptor radionuclide therapy treatment response in metastatic neuroendocrine tumors","volume":"54","author":"Zhao","year":"2025","journal-title":"Curr Probl Diagn Radiol"},{"issue":"4","key":"10.1053\/j.sult.2026.06.001_bib81","article-title":"Artificial intelligence and machine learning in the diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms-a scoping review","volume":"12","author":"Pantelis","year":"2022","journal-title":"Diagn (Basel)"},{"key":"10.1053\/j.sult.2026.06.001_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.628408","article-title":"Updated trends in imaging practices for pancreatic neuroendocrine tumors (PNETs): a systematic review and meta-analysis to pave the way for standardization in the new era of big data and artificial intelligence","volume":"11","author":"Partouche","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1053\/j.sult.2026.06.001_bib83","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s00261-020-02833-8","article-title":"New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms","volume":"47","author":"Saleh","year":"2022","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.001_bib84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40644-018-0170-8","article-title":"The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis","volume":"18","author":"Guo","year":"2018","journal-title":"Cancer Imaging"},{"key":"10.1053\/j.sult.2026.06.001_bib85","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejrad.2019.05.024","article-title":"Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics","volume":"117","author":"He","year":"2019","journal-title":"Eur J Radiol"},{"issue":"38","key":"10.1053\/j.sult.2026.06.001_bib86","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.3748\/wjg.v22.i38.8596","article-title":"Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: key immunohistochemical profiles for differential diagnosis","volume":"22","author":"Ohara","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.sult.2026.06.001_bib87","article-title":"Diagnostic accuracy and radiomic analysis of 68Ga-DOTATOC PET for preoperative assessment of lymph nodal status in well-differentiated pancreatic neuroendocrine tumours","volume":"64","author":"Bezzi","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1053\/j.sult.2026.06.001_bib88","article-title":"Dual tracer 68Ga-DOTATOC and 18F-FDG PET\/CT for preoperative risk evaluation in pancreatic neuroendocrine tumours: explorative texture analysis","volume":"60","author":"Mapelli","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.sult.2026.06.001_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1514792","article-title":"The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy","volume":"16","author":"Singh","year":"2025","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217126000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217126000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:51:40Z","timestamp":1788299500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887217126000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":89,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0887217126000284"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2026.06.001","relation":{},"ISSN":["0887-2171"],"issn-type":[{"value":"0887-2171","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic Neuroendocrine Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Seminars in Ultrasound, CT and MRI","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sult.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}